GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raily Aesthetic Medicine International Holdings Ltd (HKSE:02135) » Definitions » Cash Flow from Operations

Raily Aesthetic Medicine International Holdings (HKSE:02135) Cash Flow from Operations : HK$5.5 Mil (TTM As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Raily Aesthetic Medicine International Holdings Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Jun. 2023, Raily Aesthetic Medicine International Holdings's Net Income From Continuing Operations was HK$-3.1 Mil. Its Depreciation, Depletion and Amortization was HK$13.9 Mil. Its Change In Working Capital was HK$-5.6 Mil. Its cash flow from deferred tax was HK$0.0 Mil. Its Cash from Discontinued Operating Activities was HK$0.0 Mil. Its Asset Impairment Charge was HK$0.0 Mil. Its Stock Based Compensation was HK$2.8 Mil. And its Cash Flow from Others was HK$-0.4 Mil. In all, Raily Aesthetic Medicine International Holdings's Cash Flow from Operations for the six months ended in Jun. 2023 was HK$7.6 Mil.


Raily Aesthetic Medicine International Holdings Cash Flow from Operations Historical Data

The historical data trend for Raily Aesthetic Medicine International Holdings's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raily Aesthetic Medicine International Holdings Cash Flow from Operations Chart

Raily Aesthetic Medicine International Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Operations
Get a 7-Day Free Trial 18.90 16.78 -3.02 -2.54 -

Raily Aesthetic Medicine International Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.35 -0.46 -2.10 7.64 -

Raily Aesthetic Medicine International Holdings Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Raily Aesthetic Medicine International Holdings's Cash Flow from Operations for the fiscal year that ended in Dec. 2022 is calculated as:

Raily Aesthetic Medicine International Holdings's Cash Flow from Operations for the quarter that ended in Jun. 2023 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$5.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raily Aesthetic Medicine International Holdings  (HKSE:02135) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Raily Aesthetic Medicine International Holdings's net income from continuing operations for the six months ended in Jun. 2023 was HK$-3.1 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Raily Aesthetic Medicine International Holdings's depreciation, depletion and amortization for the six months ended in Jun. 2023 was HK$13.9 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Raily Aesthetic Medicine International Holdings's change in working capital for the six months ended in Jun. 2023 was HK$-5.6 Mil. It means Raily Aesthetic Medicine International Holdings's working capital declined by HK$5.6 Mil from Dec. 2022 to Jun. 2023 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Raily Aesthetic Medicine International Holdings's cash flow from deferred tax for the six months ended in Jun. 2023 was HK$0.0 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Raily Aesthetic Medicine International Holdings's cash from discontinued operating Activities for the six months ended in Jun. 2023 was HK$0.0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Raily Aesthetic Medicine International Holdings's asset impairment charge for the six months ended in Jun. 2023 was HK$0.0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Raily Aesthetic Medicine International Holdings's stock based compensation for the six months ended in Jun. 2023 was HK$2.8 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Raily Aesthetic Medicine International Holdings's cash flow from others for the six months ended in Jun. 2023 was HK$-0.4 Mil.


Raily Aesthetic Medicine International Holdings Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description

Traded in Other Exchanges
N/A
Address
No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN
Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.
Executives
Fu Haishu 2201 Interest of corporation controlled by you
Jin Chunmiao 2202 Interest of your spouse
Ruide Consultation Limited 2101 Beneficial owner
Youxin Management Co., Limited 2101 Beneficial owner
Beauty Milkway (hk) Limited
China Orient Asset Management (international) Holding Limited
China Orient Asset Management Co., Ltd.
Dong Yin Development (holdings) Limited
Wise Leader Assets Ltd.
Shang Hai Dong Hua Jian Kang Guan Li He Huo Qi Ye You Xian He Huo
Dong Fang Zi Chan Guan Li Zhong Guo Kong Gu You Xian Gong Si
Shen Zhen Dong Fang Chuang Ye Tou Zi You Xian Gong Si
Shen Zhen Qian Hai Cai Fu Dong Fang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Fa Zhan Ji Jin You Xian He Huo
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Tou Zi Guan Li You Xian Gong Si

Raily Aesthetic Medicine International Holdings (HKSE:02135) Headlines

No Headlines